关注
Rodrigo Romero
Rodrigo Romero
MIT and Memorial Sloan Kettering
在 mskcc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
R Romero, VI Sayin, SM Davidson, MR Bauer, SX Singh, SE LeBoeuf, ...
Nature medicine 23 (11), 1362-1368, 2017
5662017
Rapid modelling of cooperating genetic events in cancer through somatic genome editing
FJ Sánchez-Rivera, T Papagiannakopoulos, R Romero, T Tammela, ...
Nature 516 (7531), 428-431, 2014
4362014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
GR Hoffman, R Rahal, F Buxton, K Xiang, G McAllister, E Frias, ...
Proceedings of the National Academy of Sciences 111 (8), 3128-3133, 2014
4242014
Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
R Rahal, M Frick, R Romero, JM Korn, R Kridel, F Chun Chan, B Meissner, ...
Nature medicine 20 (1), 87-92, 2014
4042014
Identification of DHODH as a therapeutic target in small cell lung cancer
L Li, SR Ng, CI Colón, BJ Drapkin, PP Hsu, Z Li, CS Nabel, CA Lewis, ...
Science translational medicine 11 (517), eaaw7852, 2019
1052019
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
R Romero, FJ Sánchez-Rivera, PMK Westcott, KL Mercer, A Bhutkar, ...
Nature Cancer 1 (6), 589-602, 2020
472020
Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform
S Naranjo, CM Cabana, LM LaFave, R Romero, SL Shanahan, A Bhutkar, ...
Genes & Development 36 (15-16), 936-949, 2022
192022
Rapid interrogation of cancer cell of origin through CRISPR editing
W Feng, Z Cao, PX Lim, H Zhao, H Luo, N Mao, YS Lee, AA Rivera, ...
Proceedings of the National Academy of Sciences 118 (32), e2110344118, 2021
172021
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells
RS Patel, R Romero, EV Watson, AC Liang, M Burger, PMK Westcott, ...
Nature communications 13 (1), 256, 2022
102022
Ramirez, J.
PE Rodriguez, R Rodriguez, VMPLI De, VDA De Emergencia, ...
32005
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
R Romero, T Chu, TJ González-Robles, P Smith, Y Xie, H Kaur, S Yoder, ...
bioRxiv, 2024
12024
Methods of treating cancers having a deregulated nrf2/keap1 pathway
T Papagiannakopoulos, T Jacks, R Romero
US Patent App. 18/530,612, 2024
2024
Abstract IA17: The role of the senescence-associated secretory phenotype in cancer
RS Patel, R Romero, AC Liang, EV Watson, M Burger, PMK Westcott, ...
Cancer Immunology Research 9 (2_Supplement), IA17-IA17, 2021
2021
Publisher Correction: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
R Romero, FJ Sánchez-Rivera, PMK Westcott, KL Mercer, A Bhutkar, ...
Nature Cancer 1 (9), 935-935, 2020
2020
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1 (vol 1, pg 589, 2020)
R Romero, FJ Sanchez-Rivera, PMK Westcott, KL Mercer, A Bhutkar, ...
NATURE CANCER 1 (9), 935-935, 2020
2020
Identification of genotype-specific dependencies in Keap1-deficient lung adenocarcinoma
R Romero
Massachusetts Institute of Technology, 2019
2019
Methods of treating cancers having a deregulated nrf2/keap1 pathway
T Papagiannakopoulos, T Jacks, R Romero
2018
Abstract A43: Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities
R Romero, VI Sayin, DM Shawn, M Bauer, SX Singh, S LeBoeuf, ...
Cancer Research 78 (10_Supplement), A43-A43, 2018
2018
Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities.
R Romero, VI Sayin, DM Shawn, M Bauer, SX Singh, S LeBoeuf, ...
CANCER RESEARCH 78 (10), 50-50, 2018
2018
Abstract PR06: A functional screen of the epigenome identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.
Z Jagani, G Hoffman, R Rahal, F Buxton, G McAllister, K Xiang, E Frias, ...
Molecular Cancer Therapeutics 12 (11_Supplement), PR06-PR06, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–20